641TiP Phase Ib/II trial of pembrolizumab (pembro) + vibostolimab combination therapy in patients (Pts) with adenocarcinoma metastatic castration-resistant prostate cancer (mCRPC) or treatment-emergent neuroendocrine mCRPC (t-NE): KEYNOTE-365 cohorts G and H

Autor:	J.S. de Bono, N.D. Shore, G. Kramer, A.M. Joshua, X.T. Li, C.H. Poehlein, C. Schloss, E.Y. Yu
Rok vydání:	2021
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 32:S670-S671
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.1154
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f055ef130b3878d8a2af9f4b2bec9323 https://doi.org/10.1016/j.annonc.2021.08.1154 Zobrazit plný text záznamu